230 related articles for article (PubMed ID: 20495084)
1. Medullary thyroid carcinoma: management of lymph node metastases.
Moley JF
J Natl Compr Canc Netw; 2010 May; 8(5):549-56. PubMed ID: 20495084
[TBL] [Abstract][Full Text] [Related]
2. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: management of lymph node metastases.
Quayle FJ; Moley JF
Curr Treat Options Oncol; 2005 Jul; 6(4):347-54. PubMed ID: 15967087
[TBL] [Abstract][Full Text] [Related]
4. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
5. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.
Moley JF; DeBenedetti MK
Ann Surg; 1999 Jun; 229(6):880-7; discussion 887-8. PubMed ID: 10363903
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
8. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
9. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
Kebebew E; Kikuchi S; Duh QY; Clark OH
Arch Surg; 2000 Aug; 135(8):895-901. PubMed ID: 10922248
[TBL] [Abstract][Full Text] [Related]
11. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
12. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
13. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
Machens A; Hinze R; Thomusch O; Dralle H
World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
[TBL] [Abstract][Full Text] [Related]
14. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
15. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
16. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
17. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
19. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
20. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]